SBRA Stock Analysis — Sabra Health Care REIT
Sector: Healthcare REIT
AI Verdict
SBRA is expensive for the growth you're getting, so the premium only makes sense if its operator relationships and regulatory moat keep driving steady earnings gains.
Competitive Moat
Sabra owns and leases a diversified portfolio of senior housing and skilled nursing facilities, creating stable rental streams from long-term operator contracts. Its defensibility comes from scale in a highly regulated sector where operator relationships and compliance expertise are hard to replicate.
Summary
SBRA is notable for its exposure to post-acute and senior care real estate, a niche with high barriers to entry.
Where It Stands
SBRA trades at 29.3x next year's earnings, well above the healthcare sector median of 22x, while forward EPS growth is expected at 16.1%.
Key Metrics
- Trailing P/E: 34.0x
- Forward P/E: 29.3x
- PEG Ratio: 2.11
- Earnings Growth: +0.2%
- Revenue Growth: +0.2%
- Dividend Yield: 0.08%
- 52-Week High: $22.77
- 52-Week Low: $17.17
Analyst Consensus
11 Buy · 11 Hold · 0 Sell (22 analysts)
Bull Case
With 16.1% forward EPS growth and 17.3% trailing revenue growth, SBRA is delivering above-average expansion for a REIT.
Bear Case
At 29.3x forward earnings and a trailing PEG of 2.11, you're paying a premium the growth rate doesn't fully support.
Catalyst to Watch
Watch for operator rent coverage trends—any improvement in tenant financial health could justify the premium multiple.